Corbus Pharmaceuticals Holdings, Inc. (CRBP) intrinsic value & 10-year financials
Corbus Pharmaceuticals Holdings, Inc. (CRBP) has a Graham intrinsic value of $102.72 per share. At $4.52 on Oct 17, 2026, the stock trades 96% below that value.
- Graham intrinsic value
- $102.72
- Share price (Oct 17, 2026)
- $4.52
- Price vs Graham value
- 96% below
- Market cap
- $60.2M
- Revenue (FY2025)
- —
- Revenue growth (10-yr CAGR)
- -14.3%
- ROIC (10-yr avg)
- 221.7%
- Free cash flow (FY2025)
- -$64.5M
CRBP 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | — | -$78.5M | -$5.90 | -$64.5M | — | -69.4% |
| FY2024 | — | -$40.2M | -$3.68 | — | — | -77.7% |
| FY2023 | — | -$44.6M | -$10.31 | — | — | -235.0% |
| FY2022 | $0 | -$42.3M | -$10.15 | -$37.6M | — | -78.3% |
| FY2021 | $881.7K | -$45.6M | -$11.15 | -$48.2M | -6350.1% | -167.6% |
| FY2020 | $3.9M | -$111.3M | — | -$100.2M | -3119.2% | 716.3% |
| FY2019 | $36.1M | -$71.5M | — | -$48.5M | -213.3% | 489.5% |
| FY2018 | $4.8M | -$55.7M | — | -$32.4M | -1176.8% | 659.8% |
| FY2017 | $2.4M | -$32.4M | — | -$28.5M | -1334.4% | 634.3% |
| FY2016 | $1.9M | -$20.0M | — | -$13.9M | -1045.6% | 344.7% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Corbus Pharmaceuticals Holdings, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Corbus Pharmaceuticals Holdings, Inc. has historically struggled to out-earn its cost of capital, averaging just -20.1% ROIC.
Corbus Pharmaceuticals Holdings, Inc. has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Corbus Pharmaceuticals Holdings, Inc. is modeled at -14.3% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $102.72 per share.